American Society of Hirudotherapy

Transposition flap and skin graft techniques for optimizing anastomosis coverage

Research article published in ANZ journal of surgery (2025)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Research reportClinical LiteratureHa et al. · ANZ journal of surgery, 2025

Abstract

BACKGROUND: This study explores a novel technique combining transposition flaps with Split-Thickness Skin Grafts (STSG) to enhance anastomosis site coverage in free tissue transfer surgeries, particularly in lower limb reconstructions using Thoracodorsal Artery Perforator (TDAP) free flap procedures. This method aims to alleviate tension at the anastomosis sites, a common issue affecting reconstructive surgery success. METHODS: A retrospective analysis was conducted on 20 patients who underwent TDAP free flap procedures. These cases were chosen due to the anticipated tension at anastomosis sites, necessitating the use of transposition flaps and STSG. Surgical procedures were meticulously documented, and postoperative outcomes were monitored, focusing on complications and overall surgical success. RESULTS: The study found no instances of complete flap failure, indicating the potential efficacy of the combined approach. Minor complications included two cases of partial tip necrosis in the transposition flaps and two cases of partial graft loss in the STSGs. These issues were resolved through secondary intention healing, demonstrating the technique's ability to manage minor postoperative challenges and maintain flap viability. CONCLUSION: Integrating transposition flaps with STSG significantly improves tension management at anastomosis sites in TDAP free flap procedures. This technique not only reduces immediate postoperative complications but also supports the long-term success of reconstructive surgeries. The findings advocate for further research to confirm the efficacy of this approach in microsurgical applications, aiming to enhance patient outcomes and advance reconstructive microsurgery.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsHumansRetrospective StudiesMaleMiddle AgedFemaleAnastomosis, SurgicalSkin TransplantationAdultPlastic Surgery ProceduresFree Tissue FlapsAgedTreatment OutcomePerforator FlapPostoperative ComplicationsMicrosurgery

Summary

In 20 patients undergoing thoracodorsal artery perforator free flap procedures for lower limb reconstruction, combining transposition flaps with split-thickness skin grafts reduced anastomotic tension; minor complications included two cases each of partial flap tip necrosis and partial graft loss.

Context

This retrospective series of 20 patients undergoing thoracodorsal-artery-perforator free-flap lower-limb reconstruction described combining transposition flaps with split-thickness skin grafts to reduce tension at anastomosis sites, reporting no complete flap failures and only minor complications (two partial tip necroses, two partial graft losses) that healed by secondary intention. Contextually relevant: flap and replantation surgery is the principal modern clinical setting where medicinal leeches are used to relieve venous congestion and salvage compromised tissue, so techniques that improve flap viability define the field hirudotherapy supports. It is a small, single-arm retrospective series without a comparison group and does not involve leech therapy, so its surgical conclusions are preliminary and the leech connection is contextual.

Citation

Reference (Vancouver style)

Ha Y, Park JA, Kim YH. Transposition flap and skin graft techniques for optimizing anastomosis coverage. ANZ J Surg. 2025;95(3):533-538. doi:10.1111/ans.70035. PMID: 40035169

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 28, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.